Furthermore, Kosinska-Kaczynska et al. (2023) [45] found that pregnant women with COVID-19 exhibit elevated sFlt-1/PlGF ratios compared to healthy pregnancies, with these increases being more pronounced in severe COVID-19 cases and those with hypertensive disorders. This evidence concerns the gene PGF and COVID-19.